Ali Yılmaz (Ali Yilmaz)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Metastatic Renal Cell Carcinoma

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

Lung cancer management

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

International journal of colorectal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet Emin Buyukbayram, Zekeriya Hannarici, Ali Yılmaz, Aykut Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, Mehmet Bilici, Salim Basol Tekin
Inflammatory parameters in NSCLC with driver mutation. Lung cancer management 13 (1) (2024)
Mehmet Emin Buyukbayram, Zekeriya Hannarici, Ali Yılmaz, Aykut Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, Mehmet Bilici, Salim Basol Tekin
Inflammatory parameters in NSCLC with driver mutation. Lung cancer management 13 (1) (2024)
Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, Aykut Turhan, Alperen Akansel Çağlar, Mehmet Bilici, Salim Başol Tekin
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Future oncology (London, England) 19 (4) (2023)
Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, Aykut Turhan, Alperen Akansel Çağlar, Mehmet Bilici, Salim Başol Tekin
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Future oncology (London, England) 19 (4) (2023)
Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, Aykut Turhan, Salim Başol Tekin, Mehmet Bilici
Lipegfilgrastim may cause hyperleukocytosis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (8) (2022)
Hatice Yılmaz, Ali Yılmaz, Güzin Demirağ
Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer. Future oncology (London, England) 17 (29) (2021)
Ali Yılmaz, Melih Simsek, Zekeriya Hannarici, Mehmet E Büyükbayram, Mehmet Bilici, Salim B Tekin
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib. Future oncology (London, England) 17 (33) (2021)
Ali Yılmaz, Hatice Yılmaz, Salim Başol Tekin, Mehmet Bilici
The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer. Biomarkers in medicine 14 (9) (2020)
Ali Yılmaz, Cem Mirili, Mehmet Bilici, Salim Başol Tekin
Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Ali Yılmaz, Salim Başol Tekin, Mehmet Bilici, Hatice Yılmaz
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer. Lung 198 (4) (2020)
Ali Yılmaz, Cem Mirili, Mehmet Bilici, Salim Başol Tekin
Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. International journal of colorectal disease 35 (2) (2019)